Levetiracetam inhibits the Na + HCO 3 − transporter Ncbe/ NBCn2 ( Slc4a10 ) in the choroid plexus of mice
Acta Physiologica · 2026
DOI: 10.1111/apha.70275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Laura Øllegaard Johnsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Choroid Plexus, Levetiracetam, Sodium-Bicarbonate Symporters, Chloride-Bicarbonate Antiporters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Fonden, Danmarks Frie Forskningsfond, Aarhus Universitets Forskningsfond.
Abstract (Originalsprache)
Aim
The Na + ‐dependent Cl − /HCO 3 − exchanger Ncbe/NBCn2 ( Slc4a10 ) constitutes a major basolateral HCO 3 − uptake pathway in the choroid plexus and contributes to cerebrospinal fluid secretion and pH regulation. This study examined whether levetiracetam inhibits Ncbe/NBCn2‐mediated transport and alters cerebrospinal fluid acid–base balance, transporter abundance, and cerebrospinal fluid secretion.
Methods
The Ncbe and NBCn1 activity was assessed in heterologous expression systems as Na + ‐dependent pH recovery after intracellular acidification. Na + ‐dependent pH recovery was also measured in isolated mouse choroid plexus epithelial cells. Cerebrospinal fluid pH and apparent secretion rate were assessed in vivo after levetiracetam treatment. Acetazolamide was included as a pharmacological control for inhibition of HCO 3 − ‐dependent secretion. Transporter abundance was assessed by immunoblotting, and molecular docking was used to explore interactions between levetiracetam, Ncbe and related SLC4A transporters.
Results
Levetiracetam inhibited Ncbe‐mediated transport, whereas no levetiracetam‐sensitive NBCn1‐mediated component was detected under the same experimental conditions. In choroid plexus epithelial cells, levetiracetam reduced Na + ‐dependent pH recovery to a similar extent as pharmacological inhibition of stilbene‐sensitive transport. After 5 days of treatment, levetiracetam was associated with lower cerebrospinal fluid pH and a higher apparent cerebrospinal fluid secretion rate compared with control mice. Levetiracetam reduced Ncbe and NBCe2 abundance, while aquaporin‐1 abundance increased. Molecular docking predicted levetiracetam interactions with residues involved in Na + and HCO 3 − coordination.
Conclusion
These findings identify Ncbe as a levetiracetam‐sensitive HCO 3 − transporter in the choroid plexus and support effects on cerebrospinal fluid acid–base balance and secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Department of Chemistry, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Lasse Messell Desdorf, Jeppe Praetorius, Helle Hasager Damkier
Förderung
- Novo Nordisk Fonden
- Danmarks Frie Forskningsfond
- Aarhus Universitets Forskningsfond
Zitieren
APA
Johnsen, L. Ø., Desdorf, L. M., Jensen, N. S., Praetorius, J., & Damkier, H. H. (2026). Levetiracetam inhibits the Na + HCO 3 − transporter Ncbe/ NBCn2 ( Slc4a10 ) in the choroid plexus of mice. Acta Physiologica. https://doi.org/10.1111/apha.70275
Vancouver
Johnsen LØ, Desdorf LM, Jensen NS, Praetorius J, Damkier HH. Levetiracetam inhibits the Na + HCO 3 − transporter Ncbe/ NBCn2 ( Slc4a10 ) in the choroid plexus of mice. Acta Physiologica. 2026. doi:10.1111/apha.70275
BibTeX
@article{Johnsen2026,
author = {Johnsen, Laura Øllegaard and Desdorf, Lasse Messell and Jensen, Nicoline Stærke and Praetorius, Jeppe and Damkier, Helle Hasager},
title = {Levetiracetam inhibits the Na + HCO 3 − transporter Ncbe/ NBCn2 ( Slc4a10 ) in the choroid plexus of mice},
journal = {Acta Physiologica},
year = {2026},
doi = {10.1111/apha.70275}
}
EUVIMED